Open-House Model for Certolizumab Pegol Discount Agreements

This contract opportunity involves establishing non-exclusive discount agreements for the medication Certolizumab pegol, as per § 130a Abs. 8 SGB V. The agreements will be made under an Open-House model, allowing all interested pharmaceutical companies to participate during the application period, provided they meet the participation requirements. Individual contract negotiations will not take place, and exclusivity in supply is not guaranteed. The quantity of medication required is uncertain and will depend on demand, the number of insured individuals, prescribing behaviors of doctors, and the dispensing practices of public pharmacies. Minimum purchase quantities are not guaranteed. Interested pharmaceutical companies can download the participation documents from the German Procurement Portal (DTVP) after applying for access. Once access is granted, they can view the documents, which include the discount agreement and specified discounts, under strict confidentiality. Any sharing of these documents with third parties requires prior written consent from the contracting authority. If a company decides not to participate, all documents must be securely destroyed. The required submission documents are detailed in the 'Cover Letter' and 'Contract Conditions Explanation' available in the project room. Communication, including the submission of participation documents, will occur electronically via the DTVP portal. Participation applications can be submitted until October 7, 2025, with further deadlines available in the project room. If a deadline falls on a weekend or public holiday, the next working day will apply. Late submissions will be considered in the next application period. The discount agreement will end by October 31, 2026, regardless of the contract date. The contracting authority reserves the right to terminate the Open-House process early, especially if exclusive discount agreements are concluded, in which case existing agreements will end according to contractual terms. Based on past experiences, exclusive discount agreements typically take effect 8 to 12 months after the publication of the relevant contract notice in the EU Official Journal.